Switch Dataset:
We are collecting the most relevant tech news and provide you with a handy archive. Use the search to find mentions of your city, accelerator or favorite startup in the last 1,000 news items. If you’d like to do a more thorough search, please contact us for help.
Search for any keyword to filter the database with >10,000 news articles
| id | date | title | slug | Date | link | content | created_at | feed_id |
|---|---|---|---|---|---|---|---|---|
| 54,423 | 01/05/2026 07:05 AM | “If Figma and Lovable had a child that became an architect”: Synaps raises €3.06 million to rival AutoCAD | if-figma-and-lovable-had-a-child-that-became-an-architect-synaps-raises-euro306-million-to-rival-autocad | 01/05/2026 | Five months after launching its first beta version, Vienna-based AI canvas for architects, Synaps, has announced its €3.06 million ($3.6 million) pre-Seed investment round from US-based Plug and Play and Fil Rouge, among others. This beta debut took place in November 2025 in Tirana, and the official launch of the first full product will take place in summer 2026. “While most startups would capitalise on the initial hype, we chose an alternative path that better fits our company DNA. We wanted to demonstrate actual numbers, traction, and credibility from relevant users. For us, it was important to state that we are here to stay, having built an AI-focused product to disrupt and democratise an entire industry—a platform that most people in the architectural and real estate worlds will use on a daily basis,” said CEO Brendon Ahmeti. Founded by Brendon Ahmeti, Agron Bajraktari, and Kevin Cobaj, Synaps is the AI canvas for architectural design. It allows users to design, visualise, collaborate and present in one platform. Ahmet describes Synaps as a child of Figma and the Swedish AI-coding startup Lovable, which grew up to become an architect. The company’s tagline, “turning words into buildings,” highlights its innovative approach to building design. This shift is driven by “vibe designing” and the use of Synaps’ generative vector-based AI floorplan tool, Vecy AI. However, Synaps claims to be much more than just vibe designing via a prompt bar. Its aim is to disrupt the entire architectural drawing and rendering industry with AI. By analysing architects’ behavioural patterns, Synaps claims it has cut the number of commands by 80%, which has significantly sped up the architectural drawing process in the Synaps editor by a factor of 50 compared to existing solutions. The company reports that rendering of 2D, 3D, and video is claimed to be 100 to 1,000 times faster than with current market solutions, depending on the project’s complexity, and can be achieved with just a few words and the push of a button. “The positive consequence of this massive simplification for the estimated 200 million draftspeople worldwide, who design 95% of the world’s buildings and spend almost half their time on drawing and rendering: Synaps ends the theft of time, talent, and money spent on these mostly outdated processes, offering a solution for a fraction of the cost,” mentioned the company. Aside from this investment, the company has achieved several notable milestones after its beta launch, such as reaching 60,000 total users, 1,500 daily active users, and hundreds of paying customers. It also states that major global VCs are eager to invest, with three of the world’s ten largest VC firms currently seeking to invest in Synaps. It also claims that 6 out of the 10 most globally relevant architectural offices have already trialled or implemented Synaps, some on a daily basis. The platform has received incredible feedback from industry leaders. Synaps has reached over 10 million users via social media, including YouTube, Instagram, and LinkedIn, through viral influencer campaigns with minimal investment. Before the beta launch, it secured 10k pre-registrations. The company has also set up a US office in San Francisco. Since the beta launch, the team has grown from 4 to 17 employees, mainly filling important strategic roles. Going forward, Synaps aims to increase its user base fivefold from 60k to 300k by the end of 2026. It is on track to reach 150k users by September. The company plans to launch Version 1 in summer 2026, introducing over 20 new AI tools for drafting and post-production. Additionally, a double-digit million Seed round is expected to close by the end of 2026. Within the next six months, its San Francisco office will become fully operational. “What excites us most about Synaps is the tangible productivity impact it delivers for architecture bureaus. Rendering alone can consume an enormous share of a studio’s time – time that could otherwise go toward taking on more projects and winning more pitches. Synaps compresses that process dramatically. Equally important is the platform’s approach to collaboration: in an industry defined by fragmented tooling, an AI-native environment where the entire team works together in one place is a genuine step change,” said Christopher Polligkeit, Senior Investment Associate at Plug and Play Austria. The post “If Figma and Lovable had a child that became an architect”: Synaps raises €3.06 million to rival AutoCAD appeared first on EU-Startups. |
01/05/2026 08:10 AM | 6 | |
| 54,422 | 01/05/2026 06:39 AM | News publishers are blocking the Internet Archive’s Wayback Machine to stop AI companies from using it | news-publishers-are-blocking-the-internet-archives-wayback-machine-to-stop-ai-companies-from-using-it | 01/05/2026 | ![]() The New York Times, CNN, USA Today, The Guardian, and at least 241 other news organisations across nine countries have moved to restrict the Archive’s crawlers, a decision the Archive’s own director has called being ‘collateral damage’ in a war that is not really about them. The Internet Archive has preserved more than one trillion […] This story continues at The Next Web |
01/05/2026 08:10 AM | 3 | |
| 54,421 | 01/05/2026 12:51 AM | How Shivon Zilis Operated as Elon Musk’s OpenAI Insider | how-shivon-zilis-operated-as-elon-musks-openai-insider | 01/05/2026 | Messages presented at trial reveal how Zilis, the mother of four of Musk's children, acted as an intermediary between him and OpenAI. | 01/05/2026 01:10 AM | 4 | |
| 54,420 | 30/04/2026 11:58 PM | Y Combinator alum Skio sells for $105M cash, only raised $8M, founder says | y-combinator-alum-skio-sells-for-dollar105m-cash-only-raised-dollar8m-founder-says | 30/04/2026 | 01/05/2026 12:10 AM | 7 | ||
| 54,419 | 30/04/2026 11:00 PM | Good Luck Getting a Mac Mini for the Next ‘Several Months’ | good-luck-getting-a-mac-mini-for-the-next-several-months | 30/04/2026 | Apple CEO Tim Cook told analysts that AI adoption has happened faster than expected. | 30/04/2026 11:10 PM | 4 | |
| 54,418 | 30/04/2026 08:14 PM | Legal AI startup Legora hits $5.6B valuation and its battle with Harvey just got hotter | legal-ai-startup-legora-hits-dollar56b-valuation-and-its-battle-with-harvey-just-got-hotter | 30/04/2026 | 30/04/2026 09:10 PM | 7 | ||
| 54,413 | 30/04/2026 07:17 PM | Samsung’s founding family doubled its wealth in a year. Its workers want a share. | samsungs-founding-family-doubled-its-wealth-in-a-year-its-workers-want-a-share | 30/04/2026 | ![]() The Lee family of South Korea, which controls Samsung, has doubled its wealth in twelve months. Bloomberg’s Billionaires Index now values the dynasty’s holdings at $45.5 billion, up from $22.7 billion a year ago, propelling the Lees from tenth to third among Asia’s richest families. The catalyst is not a new product or a management […] This story continues at The Next Web |
30/04/2026 08:10 PM | 3 | |
| 54,414 | 30/04/2026 07:04 PM | OpenAI now lets you lock your ChatGPT account with a hardware key. Here is why it thinks you should. | openai-now-lets-you-lock-your-chatgpt-account-with-a-hardware-key-here-is-why-it-thinks-you-should | 30/04/2026 | ![]() OpenAI has released a security feature for ChatGPT accounts that treats them the way banks treat online banking: hardware keys, no passwords, no email recovery, and no help from customer support if you lose access. The feature, called Advanced Account Security, is an opt-in setting that requires users to authenticate with two passkeys, two hardware […] This story continues at The Next Web |
30/04/2026 08:10 PM | 3 | |
| 54,415 | 30/04/2026 06:58 PM | Meta posted its best quarter ever. The stock dropped 9 per cent. | meta-posted-its-best-quarter-ever-the-stock-dropped-9-per-cent | 30/04/2026 | ![]() Meta posted the most profitable quarter in its history and the stock dropped 9 per cent. Revenue rose 33 per cent to $56.31 billion, beating Wall Street’s estimate of $55.49 billion. Net income reached $26.8 billion, up 61 per cent year over year. And for the first time since Meta began reporting its “family” of […] This story continues at The Next Web |
30/04/2026 08:10 PM | 3 | |
| 54,417 | 30/04/2026 06:56 PM | EV startup Faraday Future paid $7.5M to company tied to founder Jia Yueting | ev-startup-faraday-future-paid-dollar75m-to-company-tied-to-founder-jia-yueting | 30/04/2026 | 30/04/2026 08:10 PM | 7 | ||
| 54,412 | 30/04/2026 06:54 PM | Musk v. Altman Kicks Off, DOJ Guts Voting Rights Unit, and Is the AI Job Apocalypse Overhyped? | musk-v-altman-kicks-off-doj-guts-voting-rights-unit-and-is-the-ai-job-apocalypse-overhyped | 30/04/2026 | In this episode of Uncanny Valley, we get into how the Elon Musk-Sam Altman trial goes way beyond their rivalry and could have major implications both for OpenAI and also the AI industry at large. | 30/04/2026 07:10 PM | 4 | |
| 54,416 | 30/04/2026 06:43 PM | Europe’s finance ministers are about to discuss an AI model none of them can access | europes-finance-ministers-are-about-to-discuss-an-ai-model-none-of-them-can-access | 30/04/2026 | ![]() Euro-area finance ministers will discuss Anthropic’s Mythos AI model with banking supervisors on Monday, according to a senior EU official. The technology that will be on the agenda is one that no government in the European Union has access to, built by a company that the United States Pentagon has designated a national security supply […] This story continues at The Next Web |
30/04/2026 08:10 PM | 3 | |
| 54,410 | 30/04/2026 06:23 PM | AI integration demands integrity, not just innovation: Amy Trahey on building accountability into an AI-driven world | ai-integration-demands-integrity-not-just-innovation-amy-trahey-on-building-accountability-into-an-ai-driven-world | 30/04/2026 | ![]() Artificial intelligence has already embedded itself into the rhythms of modern life, shaping decisions in ways that often go unnoticed. Amy Trahey, founder of Great Lakes Engineering Group, believes that integration is exactly what makes it powerful and, in many cases, risky. From her perspective in engineering, she sees AI as something that directly influences […] This story continues at The Next Web |
30/04/2026 07:10 PM | 3 | |
| 54,411 | 30/04/2026 05:54 PM | Musk calls himself ‘a fool’ on the stand as OpenAI’s lawyer dismantles his nonprofit narrative | musk-calls-himself-a-fool-on-the-stand-as-openais-lawyer-dismantles-his-nonprofit-narrative | 30/04/2026 | ![]() The tense day three of Musk v. Altman saw OpenAI’s lead attorney William Savitt use Musk’s own emails, pledge shortfalls, and Shivon Zilis texts to argue the lawsuit is a competitive grievance dressed as a charitable principle. Elon Musk called himself “a fool” for funding OpenAI, accused its leadership of “looting the nonprofit,” and clashed […] This story continues at The Next Web |
30/04/2026 07:10 PM | 3 | |
| 54,409 | 30/04/2026 05:53 PM | FDA approval, fundraising, and the reality of building in healthcare according to BioticsAI founder | fda-approval-fundraising-and-the-reality-of-building-in-healthcare-according-to-bioticsai-founder | 30/04/2026 | 30/04/2026 06:10 PM | 7 | ||
| 54,407 | 30/04/2026 05:41 PM | Elon Musk Seemingly Admits xAI Has Used OpenAI’s Models to Train Its Own | elon-musk-seemingly-admits-xai-has-used-openais-models-to-train-its-own | 30/04/2026 | While answering questions under oath, Musk argued it’s standard practice for AI labs to use their competitors’ models. | 30/04/2026 06:10 PM | 4 | |
| 54,408 | 30/04/2026 05:30 PM | OpenAI Rolls Out ‘Advanced’ Security Mode for At-Risk Accounts | openai-rolls-out-advanced-security-mode-for-at-risk-accounts | 30/04/2026 | OpenAI is rolling out Advanced Account Security for people concerned that their ChatGPT or Codex accounts could be potential targets of phishing attacks. | 30/04/2026 06:10 PM | 4 | |
| 54,404 | 30/04/2026 05:28 PM | Blue Owl made 10x its money on SpaceX and has already sold half its position | blue-owl-made-10x-its-money-on-spacex-and-has-already-sold-half-its-position | 30/04/2026 | ![]() The alternative asset manager’s co-CEO disclosed the returns on a Q1 earnings call, framing the SpaceX gain as a hedge against potential software credit losses from AI disruption, a revealing window into how private credit firms are navigating the AI era Blue Owl Capital has sold approximately half its SpaceX investment at a $1.25 trillion […] This story continues at The Next Web |
30/04/2026 06:10 PM | 3 | |
| 54,405 | 30/04/2026 05:08 PM | Spotify launches a verified badge for artists, and AI-persona accounts won’t qualify | spotify-launches-a-verified-badge-for-artists-and-ai-persona-accounts-wont-qualify | 30/04/2026 | ![]() The green checkmark, rolling out over the coming weeks, requires consistent listener engagement, platform policy compliance, and a real-world, identifiable presence. Content farms and AI-generated artist profiles are explicitly excluded at launch. Spotify has introduced a Verified by Spotify badge, a green checkmark that will appear on artist profiles and next to artist names in […] This story continues at The Next Web |
30/04/2026 06:10 PM | 3 | |
| 54,406 | 30/04/2026 04:49 PM | Navigating AI complexity with strategic finance: Sapphire CFO Solutions on the evolving role of CFOs in startups | navigating-ai-complexity-with-strategic-finance-sapphire-cfo-solutions-on-the-evolving-role-of-cfos-in-startups | 30/04/2026 | ![]() Heather Hall, a fractional CFO and founder of Sapphire CFO Solutions, observes a growing sense of AI overwhelm among startup founders. “New tools may promise greater automation and efficiency, but they also add layers of complexity to financial choices,” she says. “With more options on the table, many founders find that experienced financial guidance can […] This story continues at The Next Web |
30/04/2026 06:10 PM | 3 | |
| 54,401 | 30/04/2026 03:45 PM | Weekly funding round-up! All of the European startup funding rounds we tracked this week (Apr. 27 – May 01) | weekly-funding-round-up-all-of-the-european-startup-funding-rounds-we-tracked-this-week-apr-27-may-01 | 30/04/2026 | This article is visible for CLUB members only. If you are already a member but don’t see the content of this article, please login here. If you’re not a CLUB member yet, but you’d like to read members-only content like this one, have unrestricted access to the site and benefit from many additional perks, you can sign up here. The post Weekly funding round-up! All of the European startup funding rounds we tracked this week (Apr. 27 – May 01) appeared first on EU-Startups. |
30/04/2026 04:10 PM | 6 | |
| 54,402 | 30/04/2026 03:37 PM | Swiss BioTech startup ALP Bio raises €1.9 million to advance immune organoid and AI platform | swiss-biotech-startup-alp-bio-raises-euro19-million-to-advance-immune-organoid-and-ai-platform | 30/04/2026 | Schlieren-based ALP Bio AG today announced it has raised €1.9 million in pre-Seed financing to accelerate their platform which combines human immune organoid biology with generative AI to help antibody developers identify, understand, and reduce immunogenicity risk earlier in drug development. The round was led by Munich-based VC 42CAP, with participation from Venture Kick and a group of strategic angel investors. “Immunogenicity is one of the largest hidden costs in biologics, and the industry has accepted late-stage surprises as the norm for too long. We believe this risk should be measured and reduced years earlier than it is today. This financing lets us scale the experimental and computational foundation of our platform and partner with teams who want to make antibody development more predictable from the start,” says Dr Christian Vahlensieck, CEO of ALP Bio AG. ALP Bio’s pre-Seed round sits within a 2026 EU-Startups funding pattern around AI-enabled drug discovery, human-relevant preclinical biology, biologics infrastructure and pharma R&D data systems. The closest Swiss reference points are Zurich-based Rivia’s €13 million Series A for clinical trial data infrastructure and Geneva-based FluoSphera’s €1.23 million raise for human-relevant drug discovery tools, indicating domestic activity around BioTech infrastructure rather than only therapeutic assets. Across the wider European market, disclosed rounds for Helical, Sable Bio, Ternary Therapeutics, Generare, Nuclera and Umlaut.bio show capital moving into platforms that aim to make drug development earlier, more data-rich and more experimentally grounded. Against this backdrop, ALP Bio’s focus on combining immune organoid readouts with generative AI positions it in an adjacent segment: early risk reduction for biologics and antibody development, rather than downstream clinical execution or broad AI discovery tooling. Taken together, these reports point to over €62million in 2026 funding across comparable BioTech, BioIT, AI drug discovery and pharma infrastructure companies. The activity spans early-stage AI drug safety, molecular design, protein and antibody engineering, human-relevant discovery models and clinical trial data systems. “Our scientific conviction is that immunogenicity cannot be solved by computation alone. By combining human immune organoid readouts with AI, we can generate the type of biological feedback needed to make antibody design more informed, iterative, and ultimately more useful for discovery and optimisation teams,” adds Dr Lucas Schaus, CSO of ALP Bio AG. Founded in 2025, ALP Bio is developing an immune organoid and AI platform for immunogenicity intelligence in biologics development. The company combines human immune organoid readouts with generative AI to help drug developers predict and reduce anti-drug antibody risk earlier in antibody discovery and development. According to the company, immunogenicity, including anti-drug antibody (ADA) responses, remains one of the most difficult risks in biologics development. These immune responses can reduce therapeutic efficacy, create safety concerns, and force teams to abandon or rework programmes late in development, after they have already consumed significant time and capital. Today, most immunogenicity signals only emerge in clinical trials, when the cost of course correction is highest. ALP Bio is building a hybrid platform designed to bring more clinically relevant signal into earlier antibody decision-making. The company combines experimentally measured human immune organoid readouts with machine learning models that support risk assessment and antibody redesign. By integrating wet-lab immune biology with scalable computational design, ALP Bio aims to move developers from late-stage failure toward earlier, more actionable immunogenicity intelligence. The platform builds on human tonsil organoid technology, which models relevant immune activity in vitro, and AI models designed to learn from increasingly rich biological datasets. ALP Bio is developing the platform to support lead candidate screening, ADA risk stratification, and sequence optimisation while preserving therapeutic function. “ALP Bio is doing for biologics what high-throughput screening did for small molecules: collapsing a years-long bottleneck into a tractable design loop. Immunogenicity has held back the field for decades, and the team’s combination of immune organoid biology and sequence-level AI is the most credible attempt we have seen to address it at the source. “This is exactly the kind of frontier BioIT bet, deep science with a clear commercial wedge, where we back founders with real conviction. Christian, Lucas, and the team bring the scientific depth and commercial discipline a problem of this size demands,” says Thomas Wilke, Partner at 42CAP The pre-Seed round will be deployed to:
ALP Bio is now engaging pharmaceutical and BioTech partners interested in early-access collaborations on immunogenicity. The company is particularly focused on antibody programmes where earlier de-risking could improve candidate selection, reduce downstream uncertainty, and support better development decisions. The post Swiss BioTech startup ALP Bio raises €1.9 million to advance immune organoid and AI platform appeared first on EU-Startups. |
30/04/2026 04:10 PM | 6 | |
| 54,403 | 30/04/2026 03:29 PM | SpaceX backer 137 Ventures raises $700M for two growth-stage funds | spacex-backer-137-ventures-raises-dollar700m-for-two-growth-stage-funds | 30/04/2026 | 30/04/2026 05:10 PM | 7 | ||
| 54,400 | 30/04/2026 03:01 PM | The rise of platform-led games and why 2025 marked a shift | the-rise-of-platform-led-games-and-why-2025-marked-a-shift | 30/04/2026 | ![]() For a long time, games and the platforms they lived on were treated as separate layers. One was the product. The other was distribution. That distinction is becoming less relevant. Across the industry, there are signs that engagement is no longer driven by the game alone, but by the broader system around it. Features that […] This story continues at The Next Web |
30/04/2026 04:10 PM | 3 | |
| 54,396 | 30/04/2026 03:00 PM | Featherless.ai secures $20M to expand serverless platform for open-source AI | featherlessai-secures-dollar20m-to-expand-serverless-platform-for-open-source-ai | 30/04/2026 | Featherless.ai, a platform for running open-source AI, has secured $20 million in Series A funding to give enterprises a new path to AI independence. The round was co-led by AMD Ventures and Airbus Ventures, with participation from BMW i Ventures, Kickstart Ventures, Panache Ventures, and Wavemaker Ventures. Featherless.ai is a serverless inference platform. Its goal is to make all AI models available for serverless inference. It offers a production-ready alternative to proprietary compute environments. The platform is built on deep research. The founding team created RWKV, a breakthrough open-source architecture designed to challenge the traditional dominance of transformers. Currently cited as the fastest-growing Hugging Face inference partner, Featherless.ai supports over 30,000 open models across language, vision, and audio, enabling developers to deploy production-grade AI instantly. By hosting its core infrastructure in the US and EU and maintaining a global team across Canada, Europe, the US, Singapore, and Australia, Featherless.ai is meeting a critical demand for sovereign AI that respects jurisdictional boundaries and data privacy. A core part of the Featherless.ai mission is hardware diversity. Through a strategic collaboration with AMD, Featherless.ai ensures that the world’s most popular open-source models run natively on AMD ROCm. This provides a competitive, auditable alternative to proprietary hardware systems, giving businesses a structural cost advantage.
Sagi Paz, Head of AMD Ventures, said:
Kasper Sage, Managing Partner at BMW i Ventures, said:
Featherless.ai will use the capital to scale its global infrastructure, launch a dedicated marketplace for specialised open models and deepen its technical integration with diverse hardware architectures to continue driving down the cost of AI inference. Lead image: Eugene Cheah, CEO and co-founder of Featherless.ai. |
30/04/2026 03:10 PM | 1 |